Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 732 of 6351
-
New drug combo aims to outsmart Hard-to-Treat cancers
Disease control OngoingThis phase II ComboMATCH treatment trial tests how well AMG 510 (sotorasib) with or without panitumumab works in treating patients with KRAS G12C mutant solid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (adva…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a nerve procedure outlast another for stubborn knee pain?
Symptom relief CompletedThis prospective observational comparative study evaluates the analgesic efficacy and safety of ultrasound-guided bipolar radiofrequency ablation (BPRFA) versus phenol chemical neurolysis (PCN) of the genicular nerves in patients with chronic knee osteoarthritis (gonarthrosis) re…
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a smart gel regrow jawbone after tooth extraction?
Disease control Recruiting nowThis study aims to combine real-world research with relevant bone repair materials and techniques to improve alveolar bone resorption in extraction sockets following impacted wisdom tooth removal, while achieving effective bone preservation or promoting bone regeneration. All eli…
Sponsor: Stomatological Hospital Affiliated with Fujian Medical University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Rewiring the brain: could neurofeedback break the loop of suicidal thoughts?
Symptom relief CompletedFew treatments target core features of suicidal thoughts and behaviors in Veterans. Real-time functional magnetic resonance imaging neurofeedback can provide information regarding brain activation associated with suicide-specific rumination, defined as a "repetitive mental fixati…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Simple blood, breath, and stool tests could revolutionize colon cancer screening
Diagnosis Recruiting nowThe primary goal is to develop easy accessible diagnostic tools for high risk subjects for colon cancer in different European populations to improve early CRC detection. These CRC screening technologies would be low cost, breakthrough and of high sensitivity and specificity.
Sponsor: Firalis SA • Aim: Diagnosis
Last updated Jun 26, 2026 16:38 UTC
-
A bowl of oats a day: could it boost calcium in pregnancy?
Disease control CompletedThis study evaluates the therapeutic effects of an oat-based porridge composite on fetomaternal outcomes and calcium/ vitamin D status among hypocalcemic antenatal women. Pregnant women diagnosed with hypocalcemia are evaluated to determine the efficacy of composite cereal supple…
Sponsor: University of Lahore Hospital (ULH) • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New pill could ease daily struggles of myasthenia gravis
Disease control OngoingThe study is a randomized, double-blind, placebo-controlled, multicenter, Phase III study, to evaluate efficacy, safety and tolerability of iptacopan in patients with AChR+ gMG who are on stable SOC treatment. Participants who meet the eligibility criteria will be randomized in a…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New gel could shrink rare skin bumps in kids and adults
Disease control OngoingSELVA: A Multicenter, Phase 3 Baseline-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations The main purpose of this study is to assess the change in microcystic lymphatic malformations…
Phase 3 • Sponsor: Palvella Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for Hard-to-Treat lung cancer: drug cocktail targets resistant tumors
Disease control Recruiting nowThis phase II trial tests how well defactinib and avutometinib in combination with nivolumab works in treating patients with LKB1-mutant non-small cell lung cancer that has not responded (refractory) to an anti-PD1 treatment and may have spread from where it first started to near…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a simple blood test unlock the secrets of brain autoimmune diseases?
Knowledge-focused Recruiting nowNeurological autoimmune diseases are a group of disorders characterized by the abnormal immune response attacking the nervous system, including the brain, spinal cord and peripheral nerves. These diseases exhibit high heterogeneity, diverse clinical presentations, and are challen…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
New hope for liver cancer: drug combo targets tough cases
Disease control Recruiting nowThe purpose of this study is to determine the MTD of WGI-0301 in combination with Sorafenib for advanced Hepatocellular Carcinoma (HCC) and assess its safety and efficacy in adults with advanced unresectable HCC who have previously received PD-1 / PD-L1 immune checkpoint inhibito…
Phase 2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug aims to control angelman syndrome long-term
Disease control OngoingThe primary objective of the study is to evaluate the long-term safety profile of GTX-102 in participants with Angelman Syndrome (AS)
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
AI spots hidden heart risks in routine scans, could save thousands from heart attacks
Prevention Recruiting nowAI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-bas…
Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
New hope for rare eye disease: drug trial targets vision loss
Disease control OngoingThe goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of tinlarebant in subjects with Stargardt Disease
Phase 2/3 • Sponsor: Belite Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Engineered immune cells take on lupus and scleroderma
Disease control Recruiting nowThe goal of Safety Lead-In is to confirm the safety of tafasitamab when given to patients with SSc, SLE, and LN. The goal of Phase 1 is to find the recommended dose of AD-PluReceptor-NK cells in combination with tafasitamab and lymphodepleting chemotherapy that can be given to p…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New heart pump could be safer for High-Risk patients
Disease control OngoingSAVE-PCI is a prospective, multi-center, randomized controlled trial evaluating the safety and efficacy of NyokAssist™, a small-bore percutaneous ventricular assist device (pVAD), in comparison with intra-aortic balloon pump (IABP) in patients undergoing elective high-risk percut…
Sponsor: magAssist, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
AI could forecast stroke outcomes in real time
Knowledge-focused CompletedArtificial intelligence (AI)-powered prognostic tools and clinical decision support systems can predict the outcome of certain diseases based on a multitude of patient data at high speed, facilitating decisions by healthcare professionals. In acute ischemic stroke, the overall tr…
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
New hope for japanese patients with Hard-to-Treat chronic GVHD
Disease control OngoingThis study will be conducted to determine the clinical efficacy of axatilimab in Japanese participants with chronic graft-versus-host disease (cGVHD).
Phase 3 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Weekly chemo boost could help ovarian cancer patients who Don't respond to standard treatment
Disease control Recruiting nowSALVOVAR will be a pragmatic open-label multicenter randomized phase III trial (ratio 1:1) comparing the efficacy of the salvage weekly dose-dense regimen with those of the continuation of the standard regimen.
Phase 3 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New shot shows promise for tough psoriasis cases
Disease control CompletedThe goal of this clinical trial is to To evaluate the efficacy of subcutaneous (SC) Netakimab in adult Chinese patients with moderate to severe plaque psoriasis. Researchers will compare Netakimab to placebo to see if Netakimab works to treat plaque psoriasis.
Phase 3 • Sponsor: SPH-BIOCAD (HK) Limited • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC